Abstract
Age-related methylation may have the potential to behave as a mutator process. To clarify the physiological consequence of age-related methylation of tumor suppressor and tumor-related genes, we studied promoter methylation status in non-neoplastic cells of various organs obtained at autopsy by methylation-specific PCR. Promoter methylation status of APC, DAP-kinase, E-cadherin, GSTP1, hMLH1, p16, RASSF1A and RUNX3 genes, which are frequently silenced in certain human malignancies, was studied in non-neoplastic cells of the esophagus, stomach, small and large intestines, liver, pancreas, kidney and lung obtained from 38 Japanese autopsies. The tumor suppressor and tumor-related genes, except APC and RASSF1A, were generally unmethylated in samples obtained from people who were less than 32 years old (n=11). Methylated promoters were present at variable frequencies in a tissue-specific manner in samples obtained from people who were greater than 42 years old (n=27), although GSTP1 and hMLH1 methylation was absent or infrequent and lacked tissue specificity. In the majority of organs, the incidence of age-related methylation paralleled the reported methylation incidence in malignant counterparts. Thus, age-related methylation of a different set of genes is thought to constitute a field defect in different organs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahuja N, Li Q, Mohan AL, Baylin SB and Issa JP . (1998). Cancer Res, 58, 5489–5494.
Belinsky SA, Palmisano WA, Gilliland FD, Crooks LA, Divine KK, Winters SA, Grimes MJ, Harms HJ, Tellez CS, Smith TM, Moots PP, Lechner JF, Stidley CA and Crowell RE . (2002). Cancer Res, 62, 2370–2377.
Byun DS, Lee MG, Chae KS, Ryu BG and Chi SG . (2001). Cancer Res., 61, 7034–7038.
Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A and Kwong YL . (2003). Gut, 52, 502–506.
Esteller M, Corn PG, Baylin SB and Herman JG . (2001). Cancer Res., 61, 3225–3229.
Issa JP . (2000). Curr. Top. Microbiol. Immunol., 249, 101–118.
Jones PA and Laird PW . (1999). Nat. Genet., 2, 163–167.
Kang GH, Shim YH, Jung HY, Kim WH, Ro JY and Rhyu MG . (2001). Cancer Res., 61, 2847–2851.
Matsumura T, Makino R and Mitamura K . (2001). Clin. Cancer Res., 7, 594–599.
Nakagawa H, Nuovo GJ, Zervos EE, Martin Jr EW, Salovaara R, Aaltonen LA and de la Chapelle A . (2001). Cancer Res., 61, 6991–6995.
Nojima D, Nakajima K, Li LC, Franks J, Ribeiro-Filho L, Ishii N and Dahiya R . (2001). Mol. Carcinogen., 32, 19–27.
Paz MF, Avila S, Fraga MF, Pollan M, Capella G, Peinado MA, Sanchez-Cespedes M, Herman JG and Esteller M . (2002). Cancer Res., 62, 4519–4524.
Satoh A, Toyota M, Itoh F, Kikuchi T, Obata T, Sasaki Y, Suzuki H, Yawata A, Kusano M, Fujita M, Hosokawa M, Yanagihara K, Tokino T and Imai K . (2002). Br. J. Cancer, 86, 1817–1823.
To K-F, Leung WK, Lee T-L, Yu J, Tong JHM, Chan MWY, Ng EKW, Chung SCS and Sung JJY . (2002). Int. J. Cancer, 102, 623–628.
Tokugawa T, Sugihara H, Tani T and Hattori T . (2002). Cancer Res., 62, 4938–4944.
Tomizawa Y, Kohno T, Kondo H, Otsuka A, Nishioka M, Niki T, Yamada T, Maeshima A, Yoshimura K, Saito R, Minna JD and Yokota J . (2002). Clin. Cancer Res., 8, 2362–2368.
Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB and Issa JP . (1999a). Proc. Natl. Acad. Sci. USA, 96, 8681–8686.
Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin SB and Issa JP . (1999b). Cancer Res., 59, 5438–5442.
Tsuchiya T, Tamura G, Sato K, Endoh Y, Sakata K, Jin Z, Motoyama T, Usuba O, Kimura W, Nishizuka S, Wilson KT, James SP, Yin J, Fleisher AS, Zou T, Silverberg SG, Kong D and Meltzer SJ . (2000). Oncogene, 19, 3642–3646.
Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH and Goggins M . (2000). Cancer Res., 60, 1835–1839.
Usadel H, Brabender J, Danenberg KD, Jeronimo C, Harden S, Engles J, Danenberg PV, Yang S and Sidransky D . (2002). Cancer Res., 62, 371–375.
Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, Farinas AJ, Milchgrub S, Euhus DM, Gilcrease M, Herman J, Minna JD and Gazdar AF . (2001). Clin. Cancer Res., 7, 1998–2004.
Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S and Motoyama T . (2002). Am. J. Pathol., 161, 399–403.
Yanagawa N, Tamura G, Oizumi H, Takahashi N, Shimazaki Y and Motoyama T . (2002). Jpn. J. Cancer Res., 93, 1107–1113.
Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF and Minna JD . (2001). Cancer Res., 61, 249–255.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Waki, T., Tamura, G., Sato, M. et al. Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene 22, 4128–4133 (2003). https://doi.org/10.1038/sj.onc.1206651
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206651
Keywords
This article is cited by
-
Epigenetic regulation of aging: implications for interventions of aging and diseases
Signal Transduction and Targeted Therapy (2022)
-
DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers
BMC Cancer (2021)
-
Wandering along the epigenetic timeline
Clinical Epigenetics (2020)
-
Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue
Clinical Epigenetics (2020)
-
Insulin/insulin-like growth factor-1 signalling (IIS) based regulation of lifespan across species
Biogerontology (2017)